Keyphrases
Intensive Care
63%
Maastricht
63%
Coronavirus Disease (COVID)
63%
Critical Care
47%
Healthcare Data
39%
Generalisability
31%
Mechanically Ventilated
31%
Rotational Thromboelastometry (ROTEM)
31%
Coronary Artery Calcification
31%
Clinical Database
31%
Vectorcardiography
31%
Deep Clustering
31%
General Data Protection Regulation
31%
COVID-19 Patients
31%
Data Preparation
31%
Research Datasets
31%
Adaptation
31%
Clinical Source
31%
Source Databases
31%
Patient List
31%
Open Health Data
31%
Non-survivors
25%
Intubation
19%
Survivors
19%
Hemostasis
19%
Tissue Plasminogen Activator (t-PA)
19%
Clotting Time
19%
Preparation Method
15%
Healthcare
15%
Patient Care
15%
European Union
15%
Intensive Care Unit
14%
EXTEM
12%
Fibrinogen
12%
FIBTEM
12%
Hypercoagulability
12%
Intensive Care Unit Mortality
12%
Hs-cTnT
10%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
10%
COVID-19
9%
Netherlands
7%
Data Documentation
7%
Multidisciplinary Team
7%
Decision Support Tool
7%
Single Center
7%
Dataset Analysis
7%
Downstream Analysis
7%
Patient Data
7%
Adequate Knowledge
7%
Data Standards
7%
INIS
patients
100%
data
63%
datasets
63%
units
38%
comparative evaluations
36%
biological markers
36%
tables
31%
arteries
31%
coronaries
31%
stability
31%
covid-19
31%
protection
31%
populations
31%
regulations
31%
cluster model
31%
mortality
31%
tissues
28%
diseases
23%
plasminogen
23%
coronaviruses
18%
nonlinear problems
15%
fibrinogen
15%
variational methods
15%
trajectories
15%
numerical analysis
15%
optimization
15%
validation
15%
lysis
15%
risks
10%
peptides
9%
adjustments
7%
prothrombin
7%
dimers
7%
fibrinolysis
7%
levels
7%
european union
7%
recommendations
6%
documentation
5%
tools
5%
Medicine and Dentistry
Intensive Care
79%
Intensive Care Unit
57%
COVID-19
44%
Biological Marker
36%
Coronary Artery Calcification
31%
Vectorcardiography
31%
Thromboelastometry
31%
Health Care
31%
Patient Care
31%
Intubation
19%
Blood Stasis
19%
Tissue Plasminogen Activator
19%
Hypercoagulability
12%
Fibrinogen
12%
Amino Terminal Sequence
9%
Brain Natriuretic Peptide
9%
Patient-Data
7%
Observational Study
7%
Survival Analysis
6%
Prothrombin Time
6%
Disease Severity
6%
Fibrinolysis
6%
D-Dimer
6%